Search

Your search keyword '"Vazira Mutalova"' showing total 2 results
Start Over Author "Vazira Mutalova" Publication Year Range Last 10 years
2 results on '"Vazira Mutalova"'

1. Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

Author

Umid Eraliev, Renat Latipov, Dilorom Tursunova, Annemarie Wasley, Danni Daniels, Umed Ismoilov, Manzura Akramova, Mehri Sultanova, Dilbar Yuldashova, Bahodir Barakaev, Vazira Mutalova, Laziz Tuychiev, Erkin Musabaev, Said Sharapov, Boris Pleshkov, Dovile Videbaek, Shahin Huseynov, Kamola Safaeva, Slavica Mijatovic-Rustempasic, Michael D. Bowen, Umesh D. Parashar, and Margaret M. Cortese

Subjects
rotavirus vaccine, uzbekistan, rotavirus, vaccine effectiveness, vaccine impact, children, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950
Abstract

Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended at age 2 and 3 months. To evaluate vaccine impact, active surveillance for rotavirus diarrhea was reestablished in 2014 at 2 hospitals in Tashkent and Bukhara which had also performed surveillance during the pre-vaccine period 2005−2009. Children aged

Published
2021
Full Text
View/download PDF

2. Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

Author

Erkin Musabaev, Laziz Tuychiev, Manzura Akramova, Umid Eraliev, Renat Latipov, Kamola Safaeva, Annemarie Wasley, Boris Pleshkov, Vazira Mutalova, Mehri Sultanova, Dilbar Yuldashova, Michael D. Bowen, Dovile Videbaek, Dilorom Tursunova, Bahodir Barakaev, Said Sharapov, Danni S. Daniels, Umesh D. Parashar, Shahin Huseynov, Margaret M. Cortese, Umed Ismoilov, and Slavica Mijatovic-Rustempasic

Subjects
Diarrhea, Rotavirus, Pediatrics, medicine.medical_specialty, 030231 tropical medicine, Immunology, Central asia, Vaccines, Attenuated, medicine.disease_cause, Rotavirus disease, Rotavirus Infections, Feces, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Immunology and Allergy, Illness severity, Clinical severity, 030212 general & internal medicine, Child, Pharmacology, business.industry, Rotavirus Vaccines, Infant, Uzbekistan, Rotavirus vaccine, Gastroenteritis, Hospitalization, Child, Preschool, Immunization program, medicine.symptom, business, Research Paper
Abstract

Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended at age 2 and 3 months. To evaluate vaccine impact, active surveillance for rotavirus diarrhea was reestablished in 2014 at 2 hospitals in Tashkent and Bukhara which had also performed surveillance during the pre-vaccine period 2005−2009. Children aged

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results